ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,035.69
      -1.57%
      US Tech 100
      16,926.80
      -2.21%
      Dow Jones
      37,815.92
      -1.49%
      Brent Oil
      85.94
      -1.54%
      Bitcoin
      60,162.73
      -5.76%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. TherapeuticsMD Inc (TXMD)

      7. TherapeuticsMD Inc (TXMD) News

      TXMD

      TherapeuticsMD (TXMD)

      TherapeuticsMD Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TXMD
      DateTimeSourceHeadlineSymbolCompany
      12:53PMiHub NewswireFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      03/29/20244:00PMBusiness WireTherapeuticsMD Announces Full Year 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
      12/07/20234:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
      12/06/202311:36AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXMDTherapeuticsMD Inc
      11/17/20239:28AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TXMDTherapeuticsMD Inc
      11/17/20239:27AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
      11/14/20234:05PMBusiness WireTherapeuticsMD Announces Third Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
      08/21/20234:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
      08/21/20234:20PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
      08/18/20235:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
      08/14/20237:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TXMDTherapeuticsMD Inc
      08/14/20237:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
      08/14/20236:50AMBusiness WireTherapeuticsMD Announces Second Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
      07/19/20235:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
      07/19/20235:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
      07/19/20235:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
      07/10/20235:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
      07/06/20234:38PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
      06/30/20238:29AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TXMDTherapeuticsMD Inc
      06/29/20235:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXMDTherapeuticsMD Inc
      06/29/20235:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
      06/28/20237:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXMDTherapeuticsMD Inc
      05/17/20235:05PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TXMDTherapeuticsMD Inc
      05/17/20235:02PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TXMDTherapeuticsMD Inc
      05/15/20234:38PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TXMDTherapeuticsMD Inc
      05/15/20234:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXMDTherapeuticsMD Inc
      05/15/20234:05PMBusiness WireTherapeuticsMD Announces First Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
      05/05/20235:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXMDTherapeuticsMD Inc
      05/04/20234:40PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TXMDTherapeuticsMD Inc
      05/01/20235:03PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:TXMDTherapeuticsMD Inc
       Showing the most relevant articles for your search:NASDAQ:TXMD